SAVA
Cassava Sciences Inc
NASDAQ: SAVA · HEALTHCARE · BIOTECHNOLOGY
$1.45
+0.69% today
Updated 2026-04-30
Market cap
$142.03M
P/E ratio
—
P/S ratio
2.54x
EPS (TTM)
$-2.22
Dividend yield
—
52W range
$1 – $5
Volume
0.5M
Cassava Sciences Inc (SAVA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-0.89%
ROA
-0.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $53.92M | $6.19M | 100.00% | -1.03% | 11.48% |
| 2007 | $65.98M | $20.30M | 100.00% | 15.41% | 30.77% |
| 2008 | $63.73M | $15.35M | 100.00% | 13.67% | 24.08% |
| 2009 | $20.56M | $-3.47M | 100.00% | -32.85% | -16.86% |
| 2010 | $16.81M | $-12.02M | 100.00% | -81.52% | -71.53% |
| 2011 | $11.48M | $-2.61M | 100.00% | -30.60% | -22.75% |
| 2012 | $10.89M | $-3.45M | 100.00% | -35.79% | -31.64% |
| 2013 | $41.12M | $31.54M | 100.00% | 76.28% | 76.71% |
| 2014 | — | $-12.39M | — | — | — |
| 2015 | $0.00 | $-14.14M | — | — | — |
| 2016 | $0.00 | $-14.85M | — | — | — |
| 2017 | $0.00 | $-11.91M | — | — | — |
| 2018 | $0.00 | $-6.56M | — | — | — |
| 2019 | $0.00 | $-4.25M | — | — | — |
| 2020 | $0.00 | $-6.33M | — | — | — |
| 2021 | $0.00 | $-31.80M | — | — | — |
| 2022 | $-1800.00 | $-72.47M | 100.00% | 4,445,555.56% | 4,026,222.22% |
| 2023 | $0.00 | $-97.22M | — | — | — |
| 2024 | $0.00 | $-24.34M | — | — | — |
| 2025 | $0.00 | $-90.97M | — | — | — |